Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74760371)
Watch
English
Progress in endocrine therapy for breast carcinoma
scientific article published on 01 July 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
title
Progress in endocrine therapy for breast carcinoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
main subject
breast carcinoma
1 reference
based on heuristic
inferred from title
author name string
G N Hortobagyi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
publication date
1 July 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
number of pages
6
1 reference
based on heuristic
inferred from page(s)
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
volume
83
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
page(s)
1-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
cites work
MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Steroid-hormone receptors and survival after first relapse in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Estrogen receptor: A prognostic factor in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Survival with breast cancer: the importance of estrogen receptor quantity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Relation between estrogen receptor concentration and clinical and histological factors: their relative prognostic importance after radical mastectomy for primary breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Antiestrogens in the treatment of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Nafoxidine--an antiestrogen for the treatment of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Use of tamoxifen for breast cancer: twenty-eight years later
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Hormonal treatment of disseminated male breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Hormonal therapy for metastatic male breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Treatment of primary breast cancer with chemotherapy and tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Adjuvant tamoxifen treatment in postmenopausal patients with operable breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risks
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
High-dose progestin therapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Megestrol acetate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
New aromatase inhibitors for breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Tamoxifen (Nolvadex) versus adrenalectomy in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Ablative procedures in patients with metastatic breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Molecular mechanisms of antiestrogen action in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Tamoxifen and endometrial cancer: from experiment to patient.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
New endocrine therapies for breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Randomized adjuvant breast cancer trials in Sweden
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980701%2983%3A1%3C1%3A%3AAID-CNCR1%3E3.0.CO%3B2-X
retrieved
21 January 2018
Identifiers
DOI
10.1002/(SICI)1097-0142(19980701)83:1<1::AID-CNCR1>3.0.CO;2-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
PubMed publication ID
9655286
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9655286
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9655286%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit